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A B S T R A C T
Symptom validity test (SVT) results should be resistant against sociodemographic variables. Healthy, 
cooperative respondents should be able to pass these tests. The purpose of the study was to collect 
reference data for a selection of SVTs (Medical Symptom Validity Test, Structured Inventory of Malingered 
Symptomatology, Amsterdam Short-Term Memory Test, Emotional Numbing Test, Reliable Digit Span, 
Maximum Span Forward). A representative population-based sample of 100 German speaking Swiss 
citizens from 18 to 60 years of age was investigated. Multiple regression analyses revealed that age and 
verbal intelligence had an effect on various SVTs, whereas sex and education did not. The rate of positive 
test scores ranged from 1% (Emotional Numbing Test, Structured Inventory of Malingered Symptomatology) 
to 4% (Maximum Span Forward). One of the pertinent questions is if such positive results in reference or 
normative samples represent false positives or true positives and how to deal with the problem.
© 2013 Colegio Oficial de Psicólogos de Madrid. All rights reserved. 
Datos normativos para la población suiza de seis pruebas para evaluar la validez 
de los síntomas
R E S U M E N
Los resultados encontrados en la evaluación de la validez de los síntomas (SVT) deberían ser inmunes a las 
variables sociodemográficas. Así, los sujetos sanos y cooperadores deberían superar los tests de SVT. El ob-
jetivo de este estudio es obtener datos de referencia de una serie de pruebas utilizadas en la evaluación de 
la validez de los síntomas, en una muestra representativa de 100 ciudadanos suizos, germano-hablantes, de 
entre 18 y 60 años: Medical Symptom Validity Test, Structured Inventory of Malingered Symptomatology, 
Amsterdam Short-Term Memory Test, Emotional Numbing Test, Reliable Digit Span y Maximum Span 
Forward. Los análisis de regresión múltiple reflejaron que las variables edad e inteligencia verbal afectaron 
a los resultados de varias de las pruebas, mientras que no fue así para las variables sexo y nivel educativo. 
La tasa de resultados positivos osciló entre el 1% (Emotional Numbing Test, Structured Inventory of Malin-
gered Symptomatology) y el 4% (Maximum Span Forward). Una cuestión relevante que se desprende de 
este estudio es si dichos resultados positivos en las muestras de referencia o normativas representan suje-
tos falsos positivos o verdaderos positivos y cómo abordar este problema.
© 2013 Colegio Oficial de Psicólogos de Madrid. Todos los derechos reservados.
In forensic neuropsychological practice, symptom validity 
assessment has become common practice (Heilbronner et al., 2009; 
Sweet & Guidotti-Breting, 2013) so much that test profiles without 
appropriate validity check are considered to be incomplete and 
potentially uninterpretable. In recent years, symptom validity 
assessment has attracted increasing interest in clinical and 
rehabilitative contexts too (e.g., Carone, Bush, & Iverson, 2013; 
Göbber, Petermann, Piegza, & Kobelt, 2012). Negative response bias 
can manifest itself in two different ways (e.g., Dandachi-Fitzgerald & 
Merckelbach, 2013): 1) as false, distorted symptom report (usually in 
the form of symptom over-reporting); or 2) as distorted behavioral 
presentation of symptoms or as impairment (such as 
underperformance in cognitive assessment).
Both manifestations can occur in combination or by themselves. 
Accordingly, detection strategies focus on either underperformance 
or over-reporting. In the context of this paper, the term symptom 
validity test (SVT) refers “to any psychometric test, score, or indicator 
used to detect invalid performance on measures of cognitive or 
physical capacity, or exaggeration of subjective symptoms” (Greve, 
Bianchini, & Brewer, 2013). In this sense, the term SVT is used as the 
superordinate which includes both performance validity tests (PVTs) 
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and self-report validity tests (SRVTs). It reflects the current consensus 
in literature to use a multi-method approach in forensic evaluations 
where PVTs and SRVTs are included (Bush et al., 2005; Iverson, 
2006). Concerning the incremental validity, the SVTs in a test battery 
should not correlate highly with one another. 
Ideally, SVTs should be sensitive to underperformance or over-
reporting but, at the same time, be insensitive to any other factors 
that may influence test performance (e.g., Hartman, 2002), such as 
genuine cognitive or mental pathology, age, or education. In fact, a 
number of studies have shown such insensitivity with selected tests 
and factors. For instance, SVT usage in childhood age has shown 
promising results with most stand-alone instruments (e.g., 
Blaskewitz, Merten, & Kathmann, 2008; Carone, 2008; MacAllister, 
Nakhutina, Bender, Karantzoulis, & Carlson, 2009); education has no 
influence on Word Memory Test cutoff-based classification (Rienstra, 
Spaan, & Schmand, 2009); Test of Memory Malingering performance 
appears to be independent of older age and education (Tombaugh, 
1997) and relatively resistant against mild dementia (Rudman, 
Oyebode, Jones, & Bentham, 2011), mild mental retardation (Simon, 
2007), depression, and pain (Iverson, Le Page, Koehler, Shojania, & 
Badii, 2007). Other studies showed that age or severe cognitive 
impairment might, in fact, produce false positive results when the 
diagnostic decision is based on recommended cutoffs. Therefore, the 
authors of the Amsterdam Short-Term Memory Test (Schmand & 
Lindeboom, 2005) recommended not to give the test to patients with 
clinically obvious symptoms; Reliable Digit Span is well known to be 
dependent upon age and cognitive impairment (e.g., Blaskewitz et 
al., 2008; Kiewel, Wisdom, Bradshaw, Pastorek, & Strutt, 2012); 
performance on the Morel Emotional Numbing Test can be 
compromised in respondents of older age and with gross cognitive 
impairment (Morel, 2010).
While there is a growing body of data investigating the influence 
of genuine cognitive or mental impairment on SVT results, little 
systematic data is available about the effect of demographic variables 
on non-patient populations. Disperse data stem mostly from healthy 
full effort groups in experimental or test validation studies (e.g., 
Courtney, Dinkins, Allen, & Kuroski, 2003; Rienstra et al., 2009; 
Teichner & Wagner, 2004). The current study aimed to examine the 
influence of demographic variables on SVT scores. A selection of 
PVTs and SRVTs was given to an adult population-based sample of 
native German speakers of Swiss nationality. A related question to be 
answered by the study was to investigate rates of positive SVT results 
in a healthy sample. Positives may be false positives, but they could 
also signal underperformance or over-reporting of a portion of 
participants.
Although reference data of this kind may bear little direct 
relevance to clinical and forensic application, they may be important 
insofar as they provide information about the quality of SVTs. 
Resulting classifications as to the presence of underperformance or 
symptom over-reporting should be independent of factors such as 
gender, age, education, or intelligence and should give information 
about the validity of test profiles. In other words, SVTs must be 
constructed in a way that all or almost all healthy test takers score 
negative on them, provided that they employ full test effort in PVTs 
and respond honestly in SRVTs. Recently, Berthelson, Mulchan, 
Odland, Miller, and Mittenberg (2013) have highlighted the practical 
relevance of data from healthy people with normal effort. 
Method
Participants
A group of 100 volunteer native German speakers from 18 to 60 
years of age was studied. In Switzerland, four official languages are 
spoken. The predominant language spoken by about three quarters 
of all Swiss citizens is German. To obtain a representative sample of 
the Swiss German population, data from the Swiss Federal Statistical 
Office (Schweizerisches Bundesamt für Statistik, 2011) were 
consulted. The sample composition aimed to be representative in 
terms of age, sex, and education.
First, the population was segmented and the proportional number 
of participants for each segment (defined by age group and education) 
was computed (Table 1). According to these criteria research 
participants were recruited by the first author. Distribution of male 
and female participants was held equal throughout all segments, as 
far as feasible. The resulting sample consisted of 49 women and 51 
men with an average age of 39.4 years (SD = 11.9).
Exclusion criteria were: Mental retardation, history of brain 
injury, history of psychiatric treatment or diagnosis of a mental 
disorder (except for depression), and alcohol dependence. Moreover, 
psychologists and undergraduates of psychology were not eligible 
for inclusion. All participants who agreed to be tested and who did 
not meet any of the exclusion criteria finished testing, so no data 
were excluded from the final analyses.
A rough post hoc check of verbal intelligence (Vocabulary Test, see 
Instruments section) resulted in a mean VIQ score of 104.2 (SD = 
10.6) for the total sample; the distribution conformed to normality.
Procedure
Data collection took place between April 2012 and February 2013. 
All participants were tested individually by the first author. All 
participants were instructed to answer honestly in questionnaires 
and to give their best effort in performance tests. To ensure 
cooperation, every participant received $20 as an incentive and they 
were told that the one who showed the best performance would get 
a voucher of another $200. Before testing, the purpose of the study 
was described as gathering reference data for a number of 
psychological tests, without giving further specification. More 
detailed feedback about the purpose of the study and the general 
and the individual results was available on demand after conclusion 
of the study.
The test battery was always given in the same order of 
presentation, as described below. Testing lasted between 60 and 90 
minutes.
Table 1
Descriptive Sample Characteristics (N = 100)
Age group Level of education Total
Primary Secondary Tertiary
Primary Vocational High 
school
PET/
College
University
18-20 1 3 2 0 0 6
21-25 1 4 1 1 3 10
26-30 2 4 2 0 3 11
31-35 1 5 1 1 3 11
36-40 2 5 1 1 3 12
41-45 2 6 2 1 3 14
46-50 3 6 2 1 2 14
51-55 2 6 1 1 2 12
56-60 3 5 1 0 1 10
Total 17 44 13 6 20 100
Note. Primary = Elementary/primary school, 9 years of education; Vocational = 
Vocational school, 12-13 years of education; High school = High school level, 13 
years of education; PET = College of professional education and training, 15-16 years 
of education; University = University level, 17-19 years of education.
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Instruments
1) The Medical Symptom Validity Test (MSVT, Green, 2004) 
Learning Trials and Immediate Recognition (IR). The computerized 
German test version was used. Ten word pairs are presented on the 
computer screen, such as “lemon tree” and “hair cut”. IR consists of 
choosing one of the words in the list (e.g., “lemon”) when given a 
pair of words containing one list word and one foil word (e.g., 
“lemon” and “orange”). The recommended cutoff of < 90 was used.
2) The Structured Inventory of Malingered Symptomatology 
(SIMS, Widows & Smith, 2005; German version, Cima et al., 2003) is 
a 75-item questionnaire developed to assess endorsement of bizarre, 
unlikely, or rare symptoms. The items are combined to five subscales 
tapping the following domains: Low Intelligence, Affective Disorders, 
Neurological Impairment, Psychosis, and Amnestic Disorders. For use 
in Switzerland, minor adaptations had to be made for three items as 
previously described by Giger, Merten, Merckelbach, and Oswald 
(2010). The total score is the sum of endorsed atypical symptoms. For 
the total SIMS score we used the cutoff proposed by Cima et al. 
(2003) for the German version (> 16).
3) The MSVT, Delayed Recognition (DR), Paired Associates (PA), 
and Free Recall (FR) trials. The recognition task is the same type as 
described above for IR, but different foil words are used. A consistency 
score (CNS) from the IR and DR trials is calculated. The cutoff for DR 
and consistency is < 90. IR is followed by the PA subtest where the 
person is told the first word and is asked to add the second word 
(e.g., “lemon”, to which the correct response would be “tree”). In the 
FR subtest, the person is asked to say as many list words as possible, 
in pairs or singly. In cases where any one of three symptom validity 
indicators (IR, DR, and CNS) is positive, a profile analysis is performed 
in order to distinguish between a profile of genuine cognitive 
impairment and a profile of underperformance (for details, see 
Henry, 2009; Howe, Anderson, Kaufman, Sachs, & Loring, 2007).
4) A German-language multiple-choice Vocabulary Test 
(Wortschatztest, WST, Schmidt & Metzler, 1992) consists of 42 items 
which are made up of one target word, plus five distractors (pseudo-
words). The number of correctly identified words is often used as a 
rough estimate of verbal intelligence and premorbid cognitive 
functioning in German-speaking countries. Post hoc analysis showed 
that, in the present sample, verbal intelligence estimates correlated 
at .55 with education level.
5) The German version of the Amsterdam Short-Term Memory 
Test (ASTM, Schmand & Lindeboom, 2005) is a PVT in multiple-
choice format (three-in-five). For each of the 30 items, five examples 
of a common category (such as vehicles, colors, trees) are presented 
on the computer screen. Then, a mathematical problem is presented 
to increase perceived difficulty. Another five words of the same 
category are then presented on the screen. The task consists in 
recognizing which three words are identical to those in the first list. 
The maximum score is 90 points; the recommended cutoff of < 85 
was used in this study. An optional discontinue rule after 15 items 
was not used in this study.
6) The German adaptation of the Morel Emotional Numbing Test 
(MENT, Morel, 2010) is a 60-item forced-choice PVT specifically 
designed for detecting feigned posttraumatic stress disorder. The 
concept of the test refers to the PTSD symptom of emotional 
numbing. The task consists in correctly combining emotional 
expressions on faces with adjectives describing these emotions. 
Patients with false claims of PTSD may display implausible difficulties 
in the perception of emotions. The recommended cutoff of > 7 (and 
> 8 for ages 60 and above) was used in this study.
7) The WAIS-R subtests Digit Span Forward and Backward 
(Wechsler, 1981). A number of different embedded symptom validity 
indicators derived from test performance in the Digit subtests of the 
Wechsler memory or intelligence scales have been proposed. In the 
current study, we used the Reliable Digit Span (RDS) as first described 
by Greiffenstein, Baker, and Gola (1994). Revised cutoffs were later 
proposed to reduce elevated false-positive rates in different 
populations. Most authors today appear to recommend a cutoff of < 7, 
which was also used in the present study (e.g., Greve et al., 2013; 
Harrison, Rosenblum, & Currie, 2010; Schroeder, Twumasi-Ankrah, 
Baade, & Marshall, 2012; Suhr & Barrash, 2007). In patient populations 
with severe cognitive impairment an even lower cut score should be 
used. As a second embedded PVT we used the Maximum Span 
Forward (MSF). As with RDS, different cutoffs were proposed; for the 
present analyses we used the cut score of MSF < 5 as proposed by 
Iverson and Tulsky (2003).
8) Finally, a newly developed, but yet unpublished SRVT was 
included: the List of Indiscriminate Psychopathology (LIPP, Merten & 
Stevens, 2012). Data collection occurred in the context of ongoing 
test development, so results will be presented elsewhere.
Results
A summary of the results in the six SVTs analyzed in this study is 
given in Table 2. As was expected, most participants had no difficulties 
in passing PVTs, so the rates of positive results was low and amounted 
to a maximum of 4% for the MSF. Only one out of 100 participants 
scored positive on the SIMS, indicating elevated endorsement of 
atypical symptoms. For the MSVT, an analysis of primary symptom 
validity indicators (IR, DR, and CNS) would classify three cases as 
positives. In the subsequent analysis, one of these cases was 
categorized as a profile of genuine cognitive impairment. Therefore, 
in the final MSVT analysis this would be a negative result in terms of 
possible underperformance.
Nine participants scored positive on only one SVT while three 
obtained positive scores on two tests (Table 3). In Table 4, the exact 
frequency distributions are presented for all relevant symptom 
validity variables.
Table 2
Descriptive Parameters
Test Variable Range M (SD) Positives
MSVT IR 90–100 99.4 (1.8) 0
DR 85–100 99.2 (2.7) 2
CNS 85–100 98.7 (3.1) 2
Failure on IR, 
DR and/or 
CNS
3
Profile 
analysis
2
ASTM 84–90 88.5 (1.5) 3
MENT 0–8 2.1 (1.6) 1
SIMS 0–35 5.2 (4.3) 1
Digit Span RDS 6–14 9.4 (1.8) 3
MSF 4–8 6.2 (0.9) 4
Note. MSVT = Medical Symptom Validity Test; IR = Immediate Recognition; DR = 
Delayed Recognition; CNS = Consistency; ASTM = Amsterdam Short-Term Memory 
Test; MENT = Morel Emotional Numbing Test; SIMS = Structured Inventory of 
Malingered Symptomatology; RDS = Reliable Digit Span; MSF = Maximum Span 
Forward.
Table 3
Number of positive classifications
Number of positive tests 0 1 2 3 4 5 6
n 88 9 3 0 0 0 0
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To investigate the effects of demographic variables, multiple 
linear regression analyses were performed with SVT indicators as 
dependent variables. Besides age, education, and sex, we decided to 
include verbal intelligence estimates (as measured by the Vocabulary 
Test, WST) as independent variables. Sex and education had no effect 
on SVT scores (Table 5). Age was a relevant factor for MSVT IR and 
CNS scores, and for MENT score, with a tendency to lower performance 
at older age. Higher verbal intelligence was associated with higher 
MSVT IR and CNS scores, higher ASTM scores with fewer errors in 
MENT, and decreased symptom endorsement in SIMS with higher 
RDS and MSF scores.
Tables 6 and 7 present means and standard deviations of the SVTs, 
stratified by age (dichotomized into younger and older age group) 
and education (grouped into primary, secondary, and tertiary level). 
Table 8 shows the correlations between the SVT measures. Most 
correlations between independent SVTs were low, often not reaching 
the threshold of statistical significance.
Discussion
The present study aimed to collect reference data for six SVTs 
on a population-based representative sample of adult participants 
of working age. To our knowledge, no such representative data 
are yet available for any of the tests used in this study. The 
Table 4
Frequency Distribution in the Total Sample
MSVT ASTM MENT SIMS Digit Span
Raw 
scores
IR DR CNS Raw 
scores
Errors Total 
score
RDS MSF
100 88 90 81 90 29 0 15 0 2 15 0 8 10
95 11 6 14 89 30 1 27 1 8 14 3 7 20
90 1 2 3 88 21 2 20 2 12 13 3 6 51
85 0 2 2 87 10 3 22 3 17 12 8 5 15
80 0 0 0 86 6 4 11 4 10 11 12 4 4
75 0 0 0 85 1 5 2 5 17 10 14 3 0
70 0 0 0 84 3 6 2 6 9 9 27 2 0
65 0 0 0 83 0 7 0 7 6 8 19 1 0
60 0 0 0 82 0 8 1 8 4 7 11 0 0
   < 60 0 0 0    < 82 0     > 8 0 9 4 6 3
10 4 5 0
11 3 4 0
12 1 3 0
13 0 2 0
14 2 1 0
   > 14 11 0 0
Note. 1One participant scored 35 on the SIMS. MSVT = Medical Symptom Validity Test; IR = Immediate Recognition; DR = Delayed Recognition; CNS = Consistency; ASTM = 
Amsterdam Short-Term Memory Test; MENT = Morel Emotional Numbing Test; SIMS = Structured Inventory of Malingered Symptomatology; RDS = Reliable Digit Span; MSF = 
Maximum Span Forward.
Table 5
Test Scores (Means and Standard Deviations) for the Subtests of the Medical Symptom Validity Test Stratified by Education and Age Groups
Level of education Age Group IR DR CNS PA FR
Primary 18–40 99.3 (1.9) 97.9 (5.7) 98.6 (3.8) 78.6 (23.4) 65.0 (10.0)
41–60 98.0 (3.5) 98.0 (4.8) 96.5 (5.3) 74.0 (24.1) 69.0 (13.5)
Secondary 18–40 99.8 (0.9) 99.6 (1.3) 99.5 (1.6) 93.6 (11.9) 82.3 (11.2)
41–60 99.1 (1.9) 99.5 (2.0) 98.6 (3.2) 90.7 (12.8) 77.6 (14.2)
Tertiary 18–40 99.7 (1.3) 99.0 (2.8) 98.7 (3.0) 96.7 (8.2) 84.0 (12.6)
41–60 99.6 (1.5) 99.6 (1.5) 99.1 (2.0) 97.3 (6.5) 81.8 (17.4)
Note. IR = Immediate Recognition; DR = Delayed Recognition; CNS = Consistency; PA = Paired Associates; FR = Free Recall.
Table 6
Test Scores (Mean and Standartd Deviations) for Five Symptom Validity Tests
Level of 
education
Age 
group
ASTM MENT SIMS RDS MSF
Primary 18–40 87.3 (1.4) 2.3 (2.0) 7.9 (4.1) 8.9 (1.9) 5.7 (1.1)
41–60 87.5 (1.5) 3.0 (2.3) 9.5 (9.5) 9.6 (2.0) 6.6 (0.8)
Secondary 18–40 88.5 (1.7) 1.3 (1.3) 5.6 (3.0) 9.2 (1.6) 6.2 (0.6)
41–60 88.8 (1.3) 2.5 (1.5) 4.4 (2.8) 9.2 (1.8) 6.0 (1.1)
Tertiary 18–40 88.7 (1.2) 1.9 (1.1) 3.6 (2.1) 9.5 (1.8) 6.1 (1.1)
41–60 89.3 (0.5) 2.4 (1.1) 2.9 (1.4) 10.4 (2.3) 6.5 (1.0)
Note. ASTM = Amsterdam Short-Term Memory Test; MENT = Morel Emotional 
Numbing Test; SIMS = Structured Inventory of Malingered Symptomatology; RDS = 
Reliable Digit Span; MSF = Maximum Span Forward.
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rationale of the selection was 1) to cover a spectrum of 
instruments that tap both underperformance and symptom over-
reporting, 2) to resort to both stand-alone and embedded 
measures, and 3) to select instruments that are in practical use in 
German speaking countries. 
Recently, Rienstra et al. (2009) have published reference data for 
the Dutch version of the Word Memory Test (Green, 2003). As was 
demonstrated by these authors, and was previously shown by 
Schmand and Lindeboom (2005) for the ASTM, symptom validity 
tests appear to be resilient against distorting effects when adapted 
into other languages and cultures (at least within the Western world 
and provided the adaptations were thoroughly performed). The 
primary reason for this may be the fact that traditional stand-alone 
PVTs have such a low test ceiling that the test performance is, to a 
considerable degree, resistant against many potential influencing 
factors (including the effects of brain damage).
Some factors that potentially influence both test performance and 
self-report measures are demographic variables such as sex, age, 
education, and person variables such as intelligence. Another 
purpose of this study was to investigate the effects of these factors 
on SVT scores. In fact, significant effects on a number of SVTs were 
found for both age and a rough measure of verbal intelligence. For 
the Test of Memory Malingering (TOMM), Tombaugh (1997) 
described effects of age and education in a non-patient population. 
However, a systematic body of data appears to be missing because 
only few studies focus on SVT performance in fully cooperative, 
healthy people. Their performance is usually only of interest when 
compared to other groups such as experimental malingerers. 
Although Tombaugh found that age and education of healthy 
respondents accounted for some variance in the TOMM, classification 
accuracy was not impacted by these factors. This was also true for 
the present study: despite the significant effects of age and/or verbal 
intelligence on a number of SVT scores, the recommended cutoff-
based decision making appears to be widely resistant against these 
effects in that there was no elevated rate of positive SVT scores in our 
sample.
In contrast to Tombaugh (1997), we included a measure of verbal 
intelligence, the effect of which corrected the effect of education to 
an extent that the latter was not detectable anymore. In fact, 
preliminary analyses in our data had shown some effect of education 
on selected SVTs when regression analyses were performed on age, 
sex, and education alone.
Low positive rates were found for all SVTs employed. The 
maximum rate amounted to 4% for the MSF. It is impossible to 
determine, with a sufficient degree of certainty, if the positives in 
this study were false positives or true positives. We performed an 
inspection of the 12 cases that scored positive on at least one SVT. 
With one case, the individual test profile as well as extreme elevations 
both on the SIMS and on pseudosymptom scales of the newly 
developed List of Indiscriminate Psychopathology indicated a high 
probability of symptom over-reporting. Two more test profiles were 
judged to be more likely to reflect negative response bias than valid 
results. This would result in a rate of true positive classifications of 
invalid test profiles for three out of 100 cases of the reference sample. 
For the remaining nine cases, close inspection showed that they 
were more likely to represent false positives than true positives. 
However, this post hoc classification must be considered as 
hypothetical. In contrast to real-world clinical and forensic contexts, 
no plausibility and consistency check could be performed that would 
have encompassed other sources (such as comprehensive 
neuropsychological test data, medical history, records, behavioral 
observations, reliable third party information).
With a supposed rate of 3% of participants who truly 
underperformed and/or over-reported at least in part of the test 
battery, numbers of hypothetical false positives can be derived from 
Table 9 based on adjusted numbers of Table 2.
With any normative or reference sample, it cannot be expected 
that all participants respond honestly in self-report measures and 
work with full effort in performance tests. The rate of 
Table 7
Linear Regression Analysis: Contribution of Sex, Age, Education, and Verbal 
Intelligence to Test Scores
SVT Dependent 
variable
Independent 
variable1
B t R2
MSVT IR Constant 95.50 48.06* .12
Sex –0.34 –0.95
Age –0.04 –2.24*
Education –0.08 –0.47
Verbal intelligence   0.06 2.71*
MSVT DR Constant 97.08 31.59* .05
Sex –0.78 –1.42
Age –0.02 –0.70
Education   0.02 0.09
Verbal intelligence   0.04 1.15
MSVT CNS Constant 93.96 28.01* .10
Sex –0.86 –1.43
Age –0.06 –2.07*
Education –0.14 –0.50
Verbal intelligence   0.08 2.32*
ASTM Total score Constant 83.55 55.16* .19
Sex   0.15 0.53
Age   0.02 1.20
Education   0.24 1.92
Verbal intelligence   0.03 2.11*
MENT Error score Constant   5.52 3.34* .15
Sex –0.12 –0.40
Age   0.04 3.33*
Education –0.21 1.55
Verbal intelligence –0.05 –3.04*
SIMS Total score Constant 16.14 3.60* .18
Sex   0.61 0.76
Age   0.02 0.62
Education –0.63 –1.73
Verbal intelligence –0.11 –2.23*
RDS Total score Constant   2.05 1.07 .17
Sex –0.08 –0.23
Age –0.01 –0.72
Education –0.06 –0.40
Verbal intelligence   0.08 3.79*
MSF Total score Constant   4.21 4.00* .07
Sex –0.18 –0.97
Age –0.01 –0.57
Education –0.05 0.60
Verbal intelligence   0.03 2.20*
Note. 1Sex was coded as 1 = female and 2 = male; education was coded from 1 
(primary education) to 5 (university degree). MSVT = Medical Symptom Validity 
Test; IR = Immediate Recognition; DR = Delayed Recognition; CNS = Consistency; 
ASTM = Amsterdam Short-Term Memory Test; MENT = Morel Emotional Numbing 
Test; SIMS = Structured Inventory of Malingered Symptomatology; RDS = Reliable 
Digit Span; MSF = Maximum Span Forward.
 *p < .05.
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underperformance and over-reporting in such samples varies 
depending on diverse factors, such as positive incentives to fully 
cooperate, restricted voluntariness of participation, qualification of 
the experimenter, perceived fairness of the experimenter’s behavior 
toward participants, perceived relevance of the study, or expected 
implicit or explicit consequences of test results. In undergraduate 
populations, a higher percentage of restricted cooperation must be 
expected if students are obliged to participate in studies in order to 
gain credits (An, Zakzanis, & Joordens, 2012).
As a consequence, normative and reference data are contaminated 
by invalid data to an unknown degree. Even if SVTs were included in 
such studies to adjust for invalid data, this would not solve the 
problem of deciding if positive results are exclusively false positives 
or true positives, or which cases are false and which are true positives. 
Rienstra et al. (2009) decided to exclude two participants who scored 
positive on the WMT validity indicators from their reference data, 
whereas we decided not to exclude any case. There are positive 
arguments for both procedures. Both will potentially lead to 
distortions in the accuracy of the resulting reference data as long as 
there is no definite criterion to distinguish between false and true 
positives.
Limitations of the study arise primarily from the restricted 
number of participants. As a result, the data should not be read as 
normative, but as what they are: Reference data. The reliability of 
our estimates of the influence of demographic variables on SVT 
scores is limited by reduced variance of the latter in healthy 
participants. The low variance of SVT scores also attenuates the 
intercorrelations between SVTs. The question of generalizability of 
Swiss reference data to other countries of German language and, 
more importantly, to non-German countries is obvious although, as 
mentioned in the introduction, there is some reason to suppose that 
SVT research is relatively robust against language and cultural 
distortions within the Western civilization.
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